Pharmacogenomics of cardiovascular complications in diabetes and obesity.

Abstract excerpt

Heart disease is a major cause of death in US and worldwide. The complex interplay of the mechanisms between diabetes, obesity and inflammation raises concerns for therapeutic understanding and developing treatment options for patients. Recent advances utilizing pharmacogenomics has helped researchers to probe in to disease pathophysiology and physicians to detect and, diagnose the disease in patients. The...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Atrial Fibrillation
• Share to Cardiovascular Diseases